持续的血统可塑性驱动肺癌的发展和进展
Fanchen Meng1, Jianyu Li1, Zhijun Xia1
1Department of Thoracic Surgery, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Jiangsu Cancer Hospital & Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
Clinical and translational medicine
|August 23, 2025
概括
肺癌细胞可以改变自身身份, 这种过程被称为血统可塑性, 了解这种可塑性为有效的肺癌治疗提供了新的目标.
科学领域:
- 癌症学
- 细胞生物学
- 遗传学
背景情况:
- 肺癌在组织类型 (腺癌,状癌,小细胞癌) 中表现出显著的异质性.
- 瘤细胞可以在不同状态之间转移, 证明血统可塑性 - - 将分化细胞重新编程为替代性身份.
- 基因组/表观基因组多样性和微环境线索从疾病开始就驱动可塑性.
研究的目的:
- 审查血统可塑性在肺癌进展,免疫逃生和治疗耐药性的作用.
- 整合正常肺部发育的洞察力,
- 探索针对血统可塑性的新疗法.
主要方法:
- 综合了肺癌血统可塑性的最新研究结果.
- 肺组织发育的综合见解.
- 专注于转录/表观遗传调节剂和瘤微环境因素.
- 讨论了EGFR和KRAS突变的影响.
主要成果:
- 血统可塑性是肺癌进展的重要组成部分,从早期瘤形成到转移和治疗耐药性.
- 血统转变是由基因组/表观遗传变化驱动的,并由微环境力量 (低氧,肌体/免疫细胞) 塑造的.
- 特定的驱动突变可能需要为瘤启动重新编程.
结论:
- 血统可塑性提供了一个机制框架,将肺癌的起源,进化和治疗脆弱性联系起来.
- 了解血统可塑性对于开发更有效的肺癌疗法至关重要.
- 针对血统可塑性提供了创新的治疗策略.
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


